Bliss GVS Pharma Ltd

In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby enclose a copy of the communication sent to those concerned shareholders whose dividend have remained unclaimed for a period of seven consective years or more concerning the proposed transfer of unclaimed fina dividend 2015-2016 and its corresponding shares to the IEPF Authority in pursuance of section 124(6) of the Companies Act 2013 read with Rule 6 of the Investor Education and Protection Fund Authority (Accounting Audit Transfer and Refund) Rules 2016.